Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review. Hernández-Mitre, M. P., Tong, S. Y. C., Denholm, J. T., Dore, G. J., Bowen, A. C., Lewin, S. R., Venkatesh, B., Hills, T. E., McQuilten, Z., Paterson, D. L., Morpeth, S. C., & Roberts, J. A. Clinical Pharmacokinetics, 61(10):1331–1343, October, 2022.
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review [link]Paper  doi  bibtex   
@article{hernandez-mitre_nafamostat_2022,
	title = {Nafamostat {Mesylate} for {Treatment} of {COVID}-19 in {Hospitalised} {Patients}: {A} {Structured}, {Narrative} {Review}},
	volume = {61},
	issn = {0312-5963, 1179-1926},
	shorttitle = {Nafamostat {Mesylate} for {Treatment} of {COVID}-19 in {Hospitalised} {Patients}},
	url = {https://link.springer.com/10.1007/s40262-022-01170-x},
	doi = {10.1007/s40262-022-01170-x},
	language = {en},
	number = {10},
	urldate = {2024-05-30},
	journal = {Clinical Pharmacokinetics},
	author = {Hernández-Mitre, María Patricia and Tong, Steven Y. C. and Denholm, Justin T. and Dore, Gregory J. and Bowen, Asha C. and Lewin, Sharon R. and Venkatesh, Balasubramanian and Hills, Thomas E. and McQuilten, Zoe and Paterson, David L. and Morpeth, Susan C. and Roberts, Jason A.},
	month = oct,
	year = {2022},
	pages = {1331--1343},
}

Downloads: 0